| MAD | major affective disorder; mandibulo-acral dysplasia; maximum allowable dose; methylandrostenediol; m... |
|---|---|
| MADPA | Medicaid Antidiscriminatory Drug Pricing and Patient Benefit Restoration Act |
| NADA | New Animal Drug Application |
| narco | narcotic, narcotic addict, drug enforcement agent |
| NCDA | National Council on Drug Abuse |
| drug profile |
The unique characteristics of a drug or class of drugs, including their administration, absorption, metabolism, duration of action, toxicity, and interactions with foods or other medications.
Ãâó:
|
|---|---|
| drug reaction |
Adverse and undesired reaction to a substance taken for its pharmacological effects. An estimated 15% of hospitalized patients develop toxic or allergic drug reactions. SEE: table.
Ãâó:
|
| drug receptor |
A protein-containing complex on a cell membrane that is capable of being stimulated by drugs in the extracellular fluid and translating that stimulation into an intracellular response. There may be thousands of such receptors on th
Ãâó:
|
| drug screen |
A clinical laboratory procedure that checks a patient's blood or urine sample for presence of certain drugs such as barbiturates, opioids, or amphetamines. Also called a tox screen.
Ãâó:
|
| drug testing, mandated |
The enforced testing of individuals for evidence of drug or alcohol use or abuse. Some state or federal regulatory or licensing agencies require random drug testing of employees in specific industries to ensure public safe
Ãâó:
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|